5-MMPA, a Novel Oral Treatment for Peyronie’s disease

Abstract:

Researchers from a Schengen Laboratory have tested a new active ingredient for the treatment of Peyronie’s disease.

Read this fascinating study on the treatment of this very common but not often discussed disease.

Read More